 DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc, Nasdaq: SBBP, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will report the Companys second quarter 2021 financial results and corporate highlights on August 5, 2021 at 7:30 a.m. ET. 